Vascular Medicine

Feature Article

CMR May Detect Cardiac Complications in Lupus

CMR May Detect Cardiac Complications in Lupus

Researchers sought to determine whether a cardiovascular magnetic resonance protocol may be useful for early diagnosis of heart disease in patients with systemic lupus erythematosus.

Latest Features

Questions Remain Regarding VTE Recurrence in Older Adults

Questions Remain Regarding VTE Recurrence in Older Adults

Venous thromboembolism recurrence risk may not be any higher in older patients than in younger patients.

The Role of Viral Infections and Vaccines in the Pathogenesis of Antiphospholipid Syndrome

The Role of Viral Infections and Vaccines in the Pathogenesis of Antiphospholipid Syndrome

Recent evidence links specific bacterial, viral infections, and vaccination to the development of APS, but these associations are not clear-cut.

Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population

Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population

South Asians exhibit the highest rates of ASCVD among all ethnic groups, and the highest prevalence is in younger age groups; up to 25% of myocardial infarctions in India occur in individuals younger than 40 years of age.

Rheumatic Heart Disease: Diagnosis and Management

Rheumatic Heart Disease: Diagnosis and Management

Learn about the comprehensive management of rheumatic heart disease with Jack Boyd, MD, clinical assistant professor of cardiothoracic surgery at Stanford University School of Medicine.

Bioresorbable Stents Promising But Metal Stents Still Have Role in Coronary Intervention

Bioresorbable Stents Promising But Metal Stents Still Have Role in Coronary Intervention

Experts say bioresorbable stents are "a few generations away" from being standard of care in interventional cardiology.

Interventional Cardiology: A Look Back at 4 Decades of Practice-Changing Innovation

Interventional Cardiology: A Look Back at 4 Decades of Practice-Changing Innovation

An overview of the groundbreaking technology that has shaped interventional cardiology.

Mitral Valve Repair: The Evolution of Transcatheter Implantation

Mitral Valve Repair: The Evolution of Transcatheter Implantation

Repairing mitral regurgitation via transcatheter MitraClip has become a promising therapeutic option for high surgical risk patients.

Transcatheter Aortic Valve Replacement: Current and Emerging Approaches

Transcatheter Aortic Valve Replacement: Current and Emerging Approaches

Transcatheter aortic valve replacement continues to evolve as a treatment for patients with symptomatic severe aortic stenosis, as well as for younger, lower-risk patients.

A Case of Heart Failure Secondary to Mitral Regurgitation

A Case of Heart Failure Secondary to Mitral Regurgitation

Although surgery remains the gold standard in mitral valve repair, percutaneous repair is a new option in the treatment armamentarium, particularly in high-risk settings.

Latest News

CMR May Detect Cardiac Complications in Lupus

CMR May Detect Cardiac Complications in Lupus

Researchers sought to determine whether a cardiovascular magnetic resonance protocol may be useful for early diagnosis of heart disease in patients with systemic lupus erythematosus.

FDA: Class I Recall of Test Strips Due to Inaccurate INR Results

FDA: Class I Recall of Test Strips Due to Inaccurate INR Results

Over 1.1 million packages of test strips distributed from January 12, 2018 to October 29, 2018 are being recalled.

Thromboembolism Risk Linked to New-Onset Atrial Fibrillation After Noncardiac Surgery

Thromboembolism Risk Linked to New-Onset Atrial Fibrillation After Noncardiac Surgery

New-onset atrial fibrillation developed after noncardiac surgery is associated with a long-term risk of thromboembolism.

Rivaroxaban in VTE: Lower Clinical Event Costs, But Higher Healthcare Costs

Rivaroxaban in VTE: Lower Clinical Event Costs, But Higher Healthcare Costs

Rivaroxaban was associated with lower clinical event costs but higher total healthcare costs compared with aspirin in patients with venous thromboembolism.

Metformin May Improve Vascular Health in Adolescents With Type 1 Diabetes

Metformin May Improve Vascular Health in Adolescents With Type 1 Diabetes

Metformin improved insulin resistance regardless of baseline BMI in adolescents with type 1 diabetes.

Improved Cardiovascular Event Reporting Needed in Leukemia Clinical Trials

Improved Cardiovascular Event Reporting Needed in Leukemia Clinical Trials

Second- and third-generation tyrosine kinase inhibitors are associated with a variety of cardiovascular events.

Class 1 Device Recall: Endologix AFX Device Recalled Due to Type III Endoleaks

Class 1 Device Recall: Endologix AFX Device Recalled Due to Type III Endoleaks

The US Food and Drug Administration has identified this as a Class I recall, with continued device use resulting in serious injury or death.

Rivaroxaban Approved to Reduce Risk of Major Cardiovascular Events in CAD, PAD

Rivaroxaban Approved to Reduce Risk of Major Cardiovascular Events in CAD, PAD

The FDA has approved Xarelto (rivaroxaban) to reduce the risk of MACE, such as CV death, myocardial infarction and stroke, in patients with chronic coronary or peripheral artery disease.

Femoral Artery Atherosclerosis More Common in Psoriasis

Femoral Artery Atherosclerosis More Common in Psoriasis

The results indicated that participants with psoriasis had a significantly higher prevalence of femoral plaques compared with control patients.

Anti-Nicotine Monoclonal Antibody Gets Orphan Drug Status for Buerger's Disease

Anti-Nicotine Monoclonal Antibody Gets Orphan Drug Status for Buerger's Disease

Buerger's disease is a nonatherosclerotic, segmental inflammatory disorder that affects small and medium vessels of the upper and lower extremities and is strongly associated with tobacco exposure.

Sign Up for Free e-Newsletters